UnitedHealth Group (NYSE:UNH) Stock Falls 1.7% – Here’s Why

UnitedHealth Group Incorporated (NYSE:UNH)’s stock price was down 1.7% during trading on Monday. The stock traded as low as $394.11 and last traded at $400.1890. 5,858,418 shares changed hands during mid-day trading, a decline of 19% from the average session volume of 7,254,990 shares. The stock had previously closed at $406.97.

Key Headlines Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Healthcare-sector strength, reportedly lifted by CVS’s better-than-expected results, helped support UNH shares. UnitedHealth Gains as CVS Earnings Beat Lifts Managed-Care Sector
• Positive Sentiment: UnitedHealth’s board declared a quarterly dividend of $2.32 per share—$9.28 annualized, equivalent to a reported 2.3% yield. Shareholders of record December 7 are due payment December 15. UnitedHealth Group Board Authorizes Payment of Quarterly Dividend
• Negative Sentiment: Sen. Elizabeth Warren renewed calls for scrutiny of UnitedHealth’s scale following its Amedisys deal, arguing the acquisition increases its influence over care and costs. Mark Cuban also warned that AI could disrupt large healthcare companies, explicitly including UNH. These are potential longer-term regulatory and business-model risks, not announcements of new action against the company. UnitedHealth Draws Breakup Pressure as AI Threat Enters the Story

Analyst Ratings Changes

A number of research analysts recently commented on the stock. New Street Research set a $402.00 price target on shares of UnitedHealth Group in a research note on Friday, October 9th. Mizuho upped their target price on UnitedHealth Group from $493.00 to $500.00 and gave the company an “outperform” rating in a research report on Thursday, October 22nd. Barclays lowered their target price on UnitedHealth Group from $441.00 to $440.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 14th. The Goldman Sachs Group lifted their price target on UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. Finally, DA Davidson set a $512.00 price target on UnitedHealth Group in a research note on Tuesday, July 21st. Twenty equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.

UnitedHealth Group Stock Up 1.3%

The company has a current ratio of 0.74, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The firm has a market cap of $367.68 billion, a price-to-earnings ratio of 19.82, a PEG ratio of 1.46 and a beta of 0.51. The firm’s 50 day simple moving average is $390.73 and its two-hundred day simple moving average is $363.43.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm had revenue of $112.72 billion for the quarter, compared to analyst estimates of $111.31 billion. During the same quarter in the prior year, the business posted $2.59 EPS. The business’s revenue was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Monday, December 7th. UnitedHealth Group’s dividend payout ratio (DPR) is 53.00%.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Patrick Conway sold 1,169 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares in the company, valued at approximately $5,977,920. This represents a 7.09% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.19% of the company’s stock.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently bought and sold shares of UNH. BlackRock Inc. raised its position in UnitedHealth Group by 4.6% during the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after purchasing an additional 3,395,530 shares in the last quarter. State Street Corp boosted its holdings in shares of UnitedHealth Group by 0.7% in the 2nd quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after purchasing an additional 301,081 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of UnitedHealth Group by 6.1% in the 2nd quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after purchasing an additional 616,723 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of UnitedHealth Group by 5.8% in the 2nd quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock valued at $4,436,923,000 after purchasing an additional 583,536 shares during the last quarter. Finally, Corient Private Wealth LP raised its holdings in shares of UnitedHealth Group by 1,443.7% during the 2nd quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate’s stock worth $3,510,920,000 after buying an additional 7,900,011 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.